Clinical Trial Update: SGLT-2 Inhibitor and High-Dose Furosemide Plus Small-Volume Hypertonic Saline Solution in Acute HF [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update investigating an SGLT-2 inhibitor combined with high-dose furosemide and small-volume hypertonic saline in patients with acute h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Preserved Ejection Fraction
• Heart Failure with Reduced Ejection Fraction
• Type 2 Diabetes Mellitus

Drugs mentioned

• FUROSEMIDE (Furosemide)
• Hypertonic saline solution (Hypertonic saline)
• SGLT-2 inhibitor

Snippet

Sponsor: University of Palermo | Conditions: Heart Failure Acute, Diabetes Type 2 | Phase 4 | Status: NOT_YET_RECRUITING